Article ; Online: Mental health conditions and contraception: current landscape, reproductive health and obstetric outcomes, and clinical guidance.
Current opinion in obstetrics & gynecology
2024 Volume 36, Issue 2, Page(s) 81–87
Abstract: Purpose of review: This review presents the epidemiology of mental health conditions among reproductive aged people, common adverse reproductive outcomes, the hormonal profile of contraception and its relationship with psychiatric outcomes, and updated ... ...
Abstract | Purpose of review: This review presents the epidemiology of mental health conditions among reproductive aged people, common adverse reproductive outcomes, the hormonal profile of contraception and its relationship with psychiatric outcomes, and updated information for clinicians providing contraceptive counselling for this population. Recent findings: There is variability among contraceptive behaviours and patterns across those who have mental health conditions, impacting reproductive, psychiatric, and perinatal outcomes. The endocrinology of hormonal contraceptives is well understood, however, the impacts of steroidal hormones on mental health outcomes continue to be less understood. Overall, hormonal contraceptives are safe to use among those with mental health conditions, and among those using selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors. Additional considerations are needed when prescribing contraception among people who may be at risk of poor adherence, who use certain classes of antidepressants, antipsychotics, antiepileptics, and who are <6 weeks postpartum. Summary: Barriers to effective contraceptive use should be addressed and myths on negative psychiatric impacts of hormonal contraceptives should be dispelled. Healthcare clinicians should seek out opportunities to become proficient in contraception counselling to improve health outcomes among people with mental health conditions. |
---|---|
MeSH term(s) | Pregnancy ; Female ; Humans ; Adult ; Reproductive Health ; Mental Health ; Contraception/adverse effects ; Reproduction ; Contraceptives, Oral, Hormonal/adverse effects |
Chemical Substances | Contraceptives, Oral, Hormonal |
Language | English |
Publishing date | 2024-01-02 |
Publishing country | England |
Document type | Review ; Journal Article |
ZDB-ID | 1049382-7 |
ISSN | 1473-656X ; 1040-872X |
ISSN (online) | 1473-656X |
ISSN | 1040-872X |
DOI | 10.1097/GCO.0000000000000936 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 3048: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.